Valneva - Advancing vaccines for better lives
Valneva is a specialty vaccine company focused on the development, manufacturing and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 28.119 |
| 2025-03 | 32.03 |
| 2025-04 | 19.447 |
| 2025-05 | 18.576 |
| Source | Traffic Share |
|---|---|
| search | 53.79% |
| direct | 34.77% |
| referrals | 6.50% |
| social | 3.86% |
| paid referrals | 0.86% |
| 0.14% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| valneva | 1,214 | 12,140 | $0.82 |
| chickungunya: dose response phase 2 trial to assess the safety and immunogenicity of single-dose live-attenuated vaccine (vla1551) in children aged 1-11 years | 0 | 0 | $0.00 |
| valneva ligiun | 4 | 40 | $0.00 |